This content is machine translated Non-resectable BRAF-mutated melanoma 5-year data from COLUMBUS study support continued long-term benefits After five years of follow-up in the COLUMBUS study, it is clear that patients with non-resectable or metastatic melanoma with a BRAFV600 mutation benefit long-term from encorafenib in combination with…
View Post 5 min This content is machine translated Multiple Myeloma Focus on first-line therapy The innovation of recent years has long since found its way into first-line therapy in multiple myeloma. Thus, the EHA-ESMO Guidelines were amended accordingly in January. Daratumumab, a monoclonal antibody…
View Post 5 min This content is machine translated Adjuvant melanoma treatment Interim analysis of “real world” data from the DACH region For the majority of melanoma patients, much more effective therapies are available today than a few years ago. This also applies to adjuvant melanoma treatment. Many new therapeutic approaches have…
View Post 8 min This content is machine translated News in metastatic prostate cancer. What impact will the studies published in 2020/2021 have on clinical practice? The years 2020 and 2021 have brought some novelties in metastatic prostate cancer. Thus, with 177Lutetium-PSMA-617and the PARP inhibitor Olaparib, two new active substances are available. The latter is already… CME-Test
View Post 6 min This content is machine translated CAR-T cell therapy Paving the way to success With the increasing clinical application of CAR-T cells, the practical aspects of therapy are a growing concern. Which patients should receive treatment using CAR-T cells outside of clinical trials? What…
View Post 1 min This content is machine translated Pan-European survey Management of tumor pain – patient care needs. Advances in tumor pain management, as well as the increasing number of long-term survivors, have contributed significantly to a better understanding of patients’ needs during the course of the disease.…
View Post 2 min This content is machine translated Multiple myeloma Small protein is difficult for phagocytes to digest Multiple myeloma is a type of bone marrow cancer that mainly affects people over the age of 60 and in many cases cannot be cured. Researchers at the University Hospital…
View Post 3 min This content is machine translated Molecular precision oncology What are the benefits of cancer genome sequencing for children with cancer? For children with cancer who have relapsed, cancer genomic analyses can help make more accurate diagnoses, find appropriate therapy and delay disease progression. This is shown by the results of…
View Post 3 min This content is machine translated New study on patient participation Should sufferers attend tumor conferences? Finding the best treatment for sufferers with complex cancers – that’s what tumor conferences aim to do. Doctors from oncology, radiology, surgery, pathology and other disciplines talk about the disease…
View Post 3 min This content is machine translated New "keys" for eliminating cancer cells Hybrid active ingredients “Borinostats” use boron instead of carbon By bringing together pharmacy and inorganic chemistry, chemist Dr. Christoph Selg and his colleagues have succeeded in developing a group of promising potential active ingredients for cancer therapy: the so-called…
View Post 6 min This content is machine translated Lynch syndrome From suspicion to proper management Lynch syndrome, also known as HNPCC (hereditary non-polyposis colorectal cancer), is the most common inherited cause of colorectal cancer worldwide. In addition to preventive surgery, aspirin is also used for…
